Basetrophy Group Holdings Limited (Basetrophy GP) released its unaudited interim results for the six months ended 30 June 2026.
Revenue jumped 93.30% year-on-year to HK$37.26 million, driven by: • Foundation and related works: HK$26.29 million (up 36.7%). • Food & beverages trading: HK$10.97 million (vs. HK$0.02 million a year earlier).
Cost of sales rose 149.20% to HK$35.88 million, compressing gross profit to HK$1.38 million and slashing gross margin to 3.7% (1H 2025: 25.3%).
Administrative and other operating expenses fell 29.65% to HK$2.71 million, but the Group moved from an operating profit of HK$1.20 million to an operating loss of HK$1.32 million. Finance costs declined to HK$0.12 million (1H 2025: HK$0.31 million). Overall, the Group swung to a net loss of HK$1.44 million, versus a HK$0.80 million profit in the prior-year period.
Cash and bank balances decreased sharply to HK$1.45 million (31 December 2025: HK$21.67 million) after an operating cash outflow of HK$20.50 million. Inventories stood at HK$61.19 million and trade receivables climbed to HK$26.83 million. Total debt—including borrowings and lease liabilities—reduced to HK$2.78 million, giving a gearing ratio of 4.8% (end-2025: 5.3%). Equity attributable to shareholders was HK$58.94 million.
Placement proceeds raised in December 2025 totalled HK$18.60 million; by 30 June 2026, HK$17.58 million had been applied, mainly for working capital and expansion of the alcoholic-beverage trading business.
No interim dividend was declared. Headcount fell to seven full-time employees (end-2025: 14).
Outlook: Management targets deeper penetration of the Xinhui Chenpi market, enhanced supply-chain efficiency, and prudent development of the PRC alcoholic-beverage segment while maintaining operational resilience amid macro-economic uncertainties.
Comments